BILLIONTOONE, INC.
Non-invasive prenatal test for sickle cell disease using cell-free fetal DNA and optimized DNA sequencing probes
- Sector
- Medtech
- Total capital
- $224K
- Federal grants
- $224K
- 1 award · 2018
- Rank in peer group#53 of 68
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 9
- 29 pending · first 2022
- Rank in peer group#1 of 68
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · Non-invasive prenatal testing of sickle cell disease$224K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 68 peers
Line = medianMedtech · Instrument
- Federal grantsBelow median
- Granted patents#1 · top 1%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 9 granted of 38- PendingLoad Balancing Of Primers In Multiplex PcrUSPTOApplication 18954472
- PendingModified Nucleotides To Reduce Primer Dimer Formation In Multiplex PcrUSPTOApplication 18954463
- PendingLiquid Biopsy Assay For Genomic Profiling Of Circulating Tumor DnaUSPTOApplication 19032113
Show all 38 patent records
- Load Balancing Of Primers In Multiplex PcrMay 21, 2026 · Application 18954472Pending
- Modified Nucleotides To Reduce Primer Dimer Formation In Multiplex PcrMay 21, 2026 · Application 18954463Pending
- Liquid Biopsy Assay For Genomic Profiling Of Circulating Tumor DnaApr 16, 2026 · Application 19032113Pending
- Liquid Biopsy Assay For Genomic Profiling Of Circulating Tumor DnaJul 24, 2025 · Application 19033133Pending
- Target-associated Molecules For Characterization Associated With Biological TargetsMar 13, 2025 · Application 18943785Pending
- Sequencing Output Determination and Analysis with Target-Associated Molecules in Quantification Associated with Biological TargetsDec 31, 2024 · US 12,183,437Granted
- Target-associated Molecules For Characterization Associated With Biological TargetsDec 24, 2024 · US 12,176,066Granted
- Dilution Tagging For Quantification Of Biological TargetsNov 28, 2024 · Application 18789459Pending
- Molecule Counting Of Methylated Cell-free Dna For Treatment MonitoringOct 31, 2024 · Application 18762467Pending
- Dilution Tagging For Quantification Of Biological TargetsAug 27, 2024 · US 12,071,651Granted
- Molecule Counting Of Methylated Cell-free Dna For Treatment MonitoringJul 23, 2024 · US 12,043,873Granted
- Non-invasive Prenatal Testing At Early Stage Of PregnancyJul 11, 2024 · Application 18593639Pending
- Non-invasive Prenatal Testing At Early Stage Of PregnancyApr 2, 2024 · US 11,946,104Granted
- Target-associated Molecules For Characterization Associated With Biological TargetsMay 9, 2023 · US 11,646,100Granted
- Quality Control Templates Ensuring Validity Of Sequencing-based AssaysApr 18, 2023 · US 11,629,381Granted
- Quality Control Templates Ensuring Validity Of Sequencing-based AssaysJan 19, 2023 · Application 17952098Pending
- Homologous Genomic Regions For Characterization Associated With Biological TargetsDec 6, 2022 · US 11,519,024Granted
- Fragment Analysis For Quantitative Diagnostics Of Biological TargetsOct 27, 2022 · Application 17702708Pending
- Sequencing Output Determination And Analysis With Target-associated Molecules In Quantification Associated With Biological TargetsAug 30, 2022 · US 11,430,543Granted
- High Throughput Assays For Detecting Infectious Diseases Using Capillary ElectrophoresisSep 23, 2021 · Application 17210488Pending
- Target-associated Molecule Synthesis For Quantification Of Biological TargetsApplication 62541555Pending
- Modified Nucleotides To Reduce Primer Dimer Formation In Multiplex PcrApplication PCTUS2025056195Pending
- Liquid Biopsy Assay For Genomic Profiling Of Circulating Tumor DnaApplication PCTUS2025012270Pending
- Liquid Biopsy Assay For Genomic Profiling Of Circulating Tumor DnaApplication 63623108Pending
- Molecule Counting Of Methylated Cell-free Dna For Treatment MonitoringApplication 63439492Pending
- Fragment Analysis For Quantitative Diagnostics Of Biological TargetsApplication PCTUS2022021603Pending
- Molecule Counting of Methylated Cell-free DNA for Treatment MonitoringApplication 63322014Pending
- Fragment Analysis For Quantitative Diagnostics Of Biological TargetsApplication 63165014Pending
- High Throughput Orthogonal COVID-19 Assay by Quantitative Sanger (qSanger)Application 63006507Pending
- Dilution Tagging For Quantification Of Biological TargetsApplication PCTUS2019045331Pending
- Homologous Genomic Regions For Characterization Associated With Biological TargetsApplication PCTUS2019014340Pending
- Dilution Tagging For Quantification Of Biological TargetsApplication 62715175Pending
- Target-associated Molecules For Characterization Associated With Biological TargetsApplication PCTUS2018045394Pending
- Sequencing Output Determination And Analysis With Target-associated Molecules In Quantification Associated With Biological TargetsApplication PCTUS2018045419Pending
- Quality Control Templates For Ensuring Validity Of Sequencing-based AssaysApplication PCTUS2018045434Pending
- Quality Control Templates For Ensuring Validity Of Sequencing-based AssaysApplication 62614236Pending
- Analyzing Sequencing Outputs For Target-associated Molecules In Quantification Of Biological TargetsApplication 62541565Pending
- Load Balancing Of Primers In Multiplex PcrApplication PCTUS2025056121Pending
Related companies, and why
- VIC FOUNDRY INCSimilar federal contract value in Medtech · null in contracts
- Revelle Aesthetics, Inc.Similar federal contract value in Medtech · null in contracts
- VST Operating Corp.Similar federal contract value in Medtech · null in contracts
- Light New Holdings, LPSimilar federal contract value in Medtech · null in contracts
- DesertDx, LLCSimilar federal contract value in Medtech · null in contracts
- DL ANALYTICS, LLCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .